189 related articles for article (PubMed ID: 371882)
1. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
Warnatz H; Rösch W; Gerlich W; Gutmann W
Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
[TBL] [Abstract][Full Text] [Related]
2. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
3. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
Bortolotti F; Realdi G; Diodati G; Fattovich G
Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immunity in acute and chronic hepatitis.
Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.
Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R
Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438
[TBL] [Abstract][Full Text] [Related]
7. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
8. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis.
Ortona L; Laghi V; Cauda R; Nervo P
Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012
[TBL] [Abstract][Full Text] [Related]
9. IgG.antibody-dependent cell-mediated cytotoxicity against cultured liver cells in patients with chronic active hepatitis.
Nonomura A; Shintani T; Ohta G
Jpn J Exp Med; 1978 Oct; 48(5):381-92. PubMed ID: 748618
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
11. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
[TBL] [Abstract][Full Text] [Related]
12. Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection.
Mondelli MU; Bortolotti F; Pontisso P; Rondanelli EG; Williams R; Realdi G; Alberti A; Eddleston AL
Clin Exp Immunol; 1987 May; 68(2):242-50. PubMed ID: 3498568
[TBL] [Abstract][Full Text] [Related]
13. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
Nelson DL; Poplack DG; Holiman BJ; Henkart PA
Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
Kakumu S; Hara T; Gohji H; Sakamoto N
Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
[TBL] [Abstract][Full Text] [Related]
15. Antigen specific suppressor T cells from chronic hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes.
Barnaba V; Levrero M; Franco A; Zaccari C; Musca A; Balsano F
J Clin Lab Immunol; 1985 Mar; 16(3):137-42. PubMed ID: 3162024
[TBL] [Abstract][Full Text] [Related]
16. [A spectrophotometric method of determining the cytotoxic activity of HBsAg-sensitized lymphocytes].
Derechinskaia EL; Blinova TV
Lab Delo; 1989; (12):25-9. PubMed ID: 2483196
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
20. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
Ponzetto A; Arrigoni A
G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
